Encore Linear Porous Coated Hip
510(k) K974294
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK974294 | Date12 Jan 1998 | StatusActive |
Recalls
-
- Terminated Z-2242-2016
Reported failure of the instrument. The retaining ring component of a neck trial became disassembled from the body of the neck.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LPH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3358
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Encore Linear Porous Coated Hip Stem is a hip joint metal/polymer/metal semi-constrained porous coated uncemented prosthesis, designed to replace a damaged or diseased hip joint. This device features a porous coating to promote osseointegration, enabling long-term stability and fixation within the femoral canal. Its semi-constrained design limits translation and rotation, providing controlled articulation for improved biomechanical function.
This device is intended for cementless implantation in the femur and is supplied sterile for surgical use. It is classified under the FDA’s 510(k) pathway (K974294) as substantially equivalent to a predicate device, with clearance granted in 1998. The product is reusable within its intended surgical context and must be handled according to sterile surgical protocols. No MRI safety information is specified in the available data.
Other devices from Encore Orthopedics, Inc.
Questions
AI-generated answers, 19 Sep 2026
What types of hip joint issues is this device designed to address and how does it work within the body?
The Encore Linear Porous Coated Hip Stem is designed to replace a damaged or diseased hip joint by acting as a cementless, uncemented prosthesis in the femur. Its porous coating encourages osseointegration—meaning it bonds directly with the bone over time—providing long-term stability. The semi-constrained design limits movement (translation and rotation) at the joint, improving biomechanical function while reducing wear and loosening risks compared to fully constrained implants.
Is this device intended for single-use or can it be reused in multiple surgeries, and how should it be handled?
This device is reusable within its intended surgical context, meaning it can be used in multiple procedures as long as sterile protocols are maintained. Since it is supplied sterile for surgical use, it must be handled under strict aseptic conditions—similar to other reusable orthopedic implants—to prevent contamination between cases. Reuse requires adherence to manufacturer guidelines for cleaning, sterilization, and inspection.
What sizes or models are available for the Encore Linear Porous Coated Hip Stem, and how is it supplied?
The device is supplied sterile for surgical use, but specific sizes or models aren’t detailed in the provided data. Typically, uncemented hip stems come in a range of femoral diameters and lengths to accommodate different patient anatomies. For exact sizing options, refer to the manufacturer’s surgical technique guide or contact Encore Orthopedics directly, as these details are critical for preoperative planning.
Are there any special storage requirements for this device before surgery?
While the data doesn’t specify exact storage conditions, all sterile surgical implants—including this reusable hip stem—require protection from contamination. It should be stored in a clean, dry environment, sealed in its original packaging or sterile barrier, and away from sources of moisture, dust, or direct sunlight. Follow the manufacturer’s instructions for packaging integrity and expiration checks before use.
How was this device’s regulatory pathway determined, and what does that mean for its use in clinical practice?
The Encore Linear Porous Coated Hip Stem was cleared via the FDA’s 510(k) pathway (K974294) in 1998, with a decision classification of *Substantially Equivalent* (SESE) to a predicate device. This means the FDA determined it had the same intended use and technological characteristics as a previously approved hip stem, ensuring it meets safety and effectiveness standards for cementless, uncemented hip replacements. Clinically, this clearance supports its use in standard orthopedic practices for patients requiring hip arthroplasty.